Skip to main content
TipRanks
Go Ultimate75% OFF

Dianthus Therapeutics (87E) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

87E Analyst Ratings

Strong Buy
10Ratings
10Buy0Hold0Sell
Based on 10 analysts giving stock ratings to Dianthus Therapeutics in the past 3 months

87E Stock 12 Month Forecast

€128.73▲(63.99% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Dianthus Therapeutics in the last 3 months. The average price target is EUR 128.73 with a high forecast of EUR 181.45 and a low forecast of EUR 102.52. The average price target represents a 63.99% change from the last price of EUR 78.50.
Highest Price Target€181.45Average Price Target€128.73Lowest Price Target€102.52

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:87E
Price TargetArticle
Roth MKM€102.52buy30.60%UpsideReiterated11/16/26
Stifel Nicolaus€120.66buy53.71%UpsideReiterated11/13/26
H.C. Wainwright€143.35buy82.61%UpsideReiterated11/06/26
Wells Fargo€122.48buy56.02%UpsideReiterated11/05/26
Wedbush€110.68buy41.00%UpsideReiterated11/05/26
J.P. Morgan€122.48buy56.02%UpsideReiterated11/05/26
Guggenheim Analyst forecast on DE:87EUnknown AnalystNot RankedGuggenheim€181.45buy131.15%UpsideReiterated11/05/26
LifeSci Capital€113.41buy44.47%UpsideReiterated09/29/26
William Blair―buy―Reiterated09/18/26
Citi€141.53buy80.29%UpsideInitiated09/04/26
Evercore ISI€121.57buy54.87%UpsideReiterated08/10/26
Truist Financial€99.80→€116.13buy47.93%UpsideReiterated08/06/26
TD Cowen€136.09buy73.36%UpsideAssigned08/05/26
Clear Street€117.94buy50.25%UpsideReiterated08/05/26
Jefferies€119.76buy52.56%UpsideReiterated06/15/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dianthus Therapeutics

3 Months
Success Rate7/8 ratings generated profit
88%
Average Return
+48.15%

Copying Gavin Clark-Gartner's trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +48.15% per trade.

1 Year
Swayampakula Ramakanth
Swayampakula RamakanthH.C. Wainwright
Success Rate13/14 ratings generated profit
93%
Average Return
+111.05%

Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +111.05% per trade.

2 Years
Rami Katkhuda
Rami KatkhudaLifeSci Capital
Success Rate16/17 ratings generated profit
94%
Average Return
+184.29%

Copying Rami Katkhuda's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +184.29% per trade.

87E Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 87E
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy77148
Buy161917179
Hold10000
Sell00000
Strong Sell00000
total2426182117

In the current month, 87E has received 17 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 87E average Analyst price target in the past 3 months is 128.73.

87E Financial Forecast

€-3€-2.25€-1.5€-0.75€0Q1 2026Q3 2026Q4 2026
High€-0.76
Consensus€-0.87
Low€-0.98

87E Earnings Forecast

Next quarter’s earnings estimate for 87E is -EUR 0.87 with a range of -EUR 0.98 to -EUR 0.76. The previous quarter’s EPS was -EUR 0.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€273,438€546,877€820,316€1.1MQ1 2026Q3 2026Q4 2026
High€1.09M
Consensus€405K
Low€0.00

87E Sales Forecast

Next quarter’s sales forecast for 87E is EUR 404.96K with a range of EUR 0 to EUR 1.09M. The previous quarter’s sales results were EUR 1.09M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

87E Stock Forecast FAQ

What is DE:87E’s average 12-month price target, according to analysts?
Based on analyst ratings, Dianthus Therapeutics’s 12-month average price target is €128.73.
What is DE:87E’s upside potential, based on the analysts’ average price target?
Dianthus Therapeutics has 63.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dianthus Therapeutics a Buy, Sell or Hold?
Dianthus Therapeutics has a consensus rating of Strong Buy, which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is Dianthus Therapeutics’s share price target?
The average share price target for Dianthus Therapeutics is €128.73. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €181.45, and the lowest forecast is €102.52. The average share price target represents a 63.99% increase from the current price of €78.5.
What do analysts say about Dianthus Therapeutics?
Dianthus Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Dianthus Therapeutics?
To buy shares of DE:87E, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.